3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid

C95H132N22O21S — CID 162083871

IUPAC3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid
SMILES[H]/N=C(\N)NCCC[C@@H]1NC(=O)[C@H](CCCC)N(C)C(=O)[C@H](CCCC)C(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)CC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](CCCN)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H](C(=O)NCC(N)=O)NC1=O
InChIInChI=1S/C95H132N22O21S/c1-5-7-18-61-53(3)82(126)70(40-56-45-103-65-22-12-10-20-63(56)65)111-83(127)57(49-118)41-78(121)69(39-55-44-102-64-21-11-9-19-62(55)64)110-90(134)77-43-60(120)48-117(77)93(137)67(23-15-34-96)108-86(130)71(42-58-46-100-52-105-58)112-89(133)76-27-17-37-116(76)92(136)68(32-33-81(124)125)109-88(132)75-26-13-14-36-115(75)94(138)72(38-54-28-30-59(119)31-29-54)106-80(123)51-139-50-73(84(128)104-47-79(97)122)113-85(129)66(24-16-35-101-95(98)99)107-87(131)74(25-8-6-2)114(4)91(61)135/h9-12,19-22,28-31,44-46,52-53,57,60-61,66-77,102-103,118-120H,5-8,13-18,23-27,32-43,47-51,96H2,1-4H3,(H2,97,122)(H,100,105)(H,104,128)(H,106,123)(H,107,131)(H,108,130)(H,109,132)(H,110,134)(H,111,127)(H,112,133)(H,113,129)(H,124,125)(H4,98,99,101)/t53?,57-,60+,61+,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-/m0/s1
InChIKeyZCRUNDSDIDNZBI-JSONKZBPSA-N
MW1950.30 g/mol
LogP-0.63
Rot. Bonds28

About 3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid

3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid (PubChem CID 162083871) has the molecular formula C95H132N22O21S and a molecular weight of 1950.30 g/mol. Its IUPAC name is 3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid.

Molecular Properties

Compound Name3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid
PubChem CID162083871
Molecular FormulaC95H132N22O21S
Molecular Weight1950.30 g/mol
Exact Mass1948.97
IUPAC Name3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid
SMILES[H]/N=C(\N)NCCC[C@@H]1NC(=O)[C@H](CCCC)N(C)C(=O)[C@H](CCCC)C(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)CC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](CCCN)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H](C(=O)NCC(N)=O)NC1=O
InChIInChI=1S/C95H132N22O21S/c1-5-7-18-61-53(3)82(126)70(40-56-45-103-65-22-12-10-20-63(56)65)111-83(127)57(49-118)41-78(121)69(39-55-44-102-64-21-11-9-19-62(55)64)110-90(134)77-43-60(120)48-117(77)93(137)67(23-15-34-96)108-86(130)71(42-58-46-100-52-105-58)112-89(133)76-27-17-37-116(76)92(136)68(32-33-81(124)125)109-88(132)75-26-13-14-36-115(75)94(138)72(38-54-28-30-59(119)31-29-54)106-80(123)51-139-50-73(84(128)104-47-79(97)122)113-85(129)66(24-16-35-101-95(98)99)107-87(131)74(25-8-6-2)114(4)91(61)135/h9-12,19-22,28-31,44-46,52-53,57,60-61,66-77,102-103,118-120H,5-8,13-18,23-27,32-43,47-51,96H2,1-4H3,(H2,97,122)(H,100,105)(H,104,128)(H,106,123)(H,107,131)(H,108,130)(H,109,132)(H,110,134)(H,111,127)(H,112,133)(H,113,129)(H,124,125)(H4,98,99,101)/t53?,57-,60+,61+,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-/m0/s1
InChIKeyZCRUNDSDIDNZBI-JSONKZBPSA-N
XLogP-0.63
TPSA666.54 Ų
H-Bond Donors21
H-Bond Acceptors24
Rotatable Bonds28
Heavy Atoms139
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001950.30
LogP ≤ 5-0.63
H-Bond Donors ≤ 521
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid?
The IUPAC name of 3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid (CID 162083871) is 3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid.
What is the SMILES notation for 3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid?
The canonical SMILES for 3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid is [H]/N=C(\N)NCCC[C@@H]1NC(=O)[C@H](CCCC)N(C)C(=O)[C@H](CCCC)C(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)CC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](CCCN)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H](C(=O)NCC(N)=O)NC1=O.
What is the InChIKey of 3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid?
The InChIKey is ZCRUNDSDIDNZBI-JSONKZBPSA-N. The full InChI is InChI=1S/C95H132N22O21S/c1-5-7-18-61-53(3)82(126)70(40-56-45-103-65-22-12-10-20-63(56)65)111-83(127)57(49-118)41-78(121)69(39-55-44-102-64-21-11-9-19-62(55)64)110-90(134)77-43-60(120)48-117(77)93(137)67(23-15-34-96)108-86(130)71(42-58-46-100-52-105-58)112-89(133)76-27-17-37-116(76)92(136)68(32-33-81(124)125)109-88(132)75-26-13-14-36-115(75)94(138)72(38-54-28-30-59(119)31-29-54)106-80(123)51-139-50-73(84(128)104-47-79(97)122)113-85(129)66(24-16-35-101-95(98)99)107-87(131)74(25-8-6-2)114(4)91(61)135/h9-12,19-22,28-31,44-46,52-53,57,60-61,66-77,102-103,118-120H,5-8,13-18,23-27,32-43,47-51,96H2,1-4H3,(H2,97,122)(H,100,105)(H,104,128)(H,106,123)(H,107,131)(H,108,130)(H,109,132)(H,110,134)(H,111,127)(H,112,133)(H,113,129)(H,124,125)(H4,98,99,101)/t53?,57-,60+,61+,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-/m0/s1.
What are the key properties of 3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid?
3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid has a molecular weight of 1950.30 g/mol, XLogP of -0.63, 28 rotatable bonds, 21 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(1S,4S,10S,13S,16S,20R,22S,25S,28S,31S,34R,37S,40S,43R,49S)-43-[(2-amino-2-oxoethyl)carbamoyl]-16-(3-aminopropyl)-34,37-dibutyl-40-(3-carbamimidamidopropyl)-20-hydroxy-28-(hydroxymethyl)-49-[(4-hydroxyphenyl)methyl]-13-(1H-imidazol-4-ylmethyl)-25,31-bis(1H-indol-3-ylmethyl)-33,36-dimethyl-2,5,11,14,17,23,26,29,32,35,38,41,47,50-tetradecaoxo-45-thia-3,6,12,15,18,24,30,36,39,42,48,51-dodecazatetracyclo[49.4.0.06,10.018,22]pentapentacontan-4-yl]propanoic acid is sourced from PubChem (CID 162083871), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).